P. Osehobo et al., Brain-derived neurotrophic factor infusion delays amygdala and perforant path kindling without affecting paired-pulse measures of neuronal inhibitionin adult rats, NEUROSCIENC, 92(4), 1999, pp. 1367-1375
Kindling is an animal model of human temporal lobe epilepsy in which excita
bility in limbic structures is permanently enhanced by repeated stimulation
s. Kindling also increases the expression of nerve growth factor, brain-der
ived neurotrophic factor, and brain-derived neurotrophic factor receptor me
ssenger RNAs in both the hippocampus and cerebral cortex and causes structu
ral changes in the hippocampus including hilar hypertrophy. We have recentl
y shown that intraventricular nerve growth factor infusion enhances the dev
elopment of kindling, whereas blocking nerve growth factor activity retards
amygdaloid kindling. Furthermore, we have shown that nerve growth factor p
rotects against kindling-induced hilar hypertrophy. The physiological role
of brain-derived neurotrophic factor in kindling is not as clear. Acute inj
ection of brain-derived neurotrophic factor increases neuronal excitability
and causes seizures, whereas chronic brain-derived neurotrophic factor inf
usion in rats slows hippocampal kindling. In agreement with the latter, we
show here that intrahilar brain-derived neurotrophic factor infusion delays
amygdala and perforant path kindling. In addition, we show that brain-deri
ved neurotrophic factor, unlike nerve growth factor, does not protect again
st kindling-induced increases in hilar area. To test the hypothesis that br
ain-derived neurotrophic factor suppresses kindling by increasing inhibitio
n above normal levels, we performed paired-pulse measures in the perforant
path-dentate gyrus pathway. Brain-derived neurotrophic factor infused into
the hippocampus had no effect on the stimulus intensity function (input/out
put curves); there was also no significant effect on paired-pulse inhibitio
n. We then kindled the perforant path 10 days after the end of brain-derive
d neurotrophic factor treatment. Once again, kindling was retarded, showing
that the brain-derived neurotrophic factor effect is long-lasting.
These results indicate that prolonged in vivo infusion of brain-derived neu
rotrophic factor reduces, rather than increases, excitability without incre
asing inhibitory neuron function, at least as assessed by paired-pulse prot
ocols. This effect may be mediated by long-lasting effects on brain-derived
neurotrophic factor receptor regulation. (C) 1999 IBRO. Published by Elsev
ier Science Ltd.